Funding & Budget in Federal

D.C. Circuit: drug makers can't force a 340B rebate model without HHS approval — the Secretary, not manufacturers, controls the program

On July 21, 2026 the U.S. Court of Appeals for the D.C. Circuit upheld a lower court and ruled that Section 340B does not permit manufacturers (Novartis and Johnson & Johnson) to unilaterally replace up-front 340B discounts with a post-purchase rebate model unless the HHS Secretary approves it — holding, in effect, that the statute puts the Secretary and not the manufacturers in control of the program. The decision preserves the up-front-discount structure that community health centers and their contract pharmacies depend on, while leaving open whether HHS could authorize a rebate model in the future. It is a defensive win, not a permanent fix: other manufacturer proposals and HHS's own rebate-pilot review remain live.

NACHC: Integrated Behavioral Health Is Working in CHCs, but Payment Reform Has to Catch Up

NACHC's June 29 national brief argues that community health centers have proven integrated primary care and behavioral health can work, but current payment structures still underpay same-day behavioral health access, care coordination, telehealth infrastructure, and risk adjustment for complex patients. The brief cites 34 million annual CHC patients, nearly 3.3 million behavioral-health patients in 2024, telehealth adoption rising from 42% to 98% between 2019 and 2024, and Medicaid supplying 44% of total CHC revenue — making stable Medicaid coverage and VBC models central to sustaining integrated care.

HRSA Quietly Restarts the 340B Rebate Model Pilot — Revised Application Package in the Federal Register, Comments Due July 15

Four months after a federal court vacated the first 340B Rebate Model Pilot (AHA v. Kennedy, February 2026), HRSA has taken the first formal step toward Rebate Pilot 2.0: an Information Collection Request for a revised '340B Rebate Model Pilot Program Application, Implementation, and Evaluation' published in the Federal Register June 15, 2026, with public comments due July 15, 2026. A June 22 correction notice revised the estimated responses to include 11 manufacturer Pilot Program Plan submissions — signaling HRSA anticipates MORE manufacturers in the revived pilot than the ~8-9 approved in the vacated first round. Guardrails from the February joint vacatur motion still bind: any new rebate program requires fresh public notice-and-comment and an effective date no earlier than 90 days after manufacturer-application approvals, sliding the earliest realistic go-live toward late 2026 or 2027. Strategic implication for FQHCs: a rebate model converts upfront 340B discounts into after-the-fact rebates — a working-capital hit covered entities (including NACHC) fought in round one. The July 15 comment window is the 13-day action item.

CMS Issues State Medicaid Director Letter #26-003 — Chief Actuary Must Certify Section 1115 Demonstrations Won't Increase Federal Spending Starting Jan. 1, 2027

On June 11, 2026, CMS released State Medicaid Director Letter #26-003, giving states early notice of a new statutory requirement (Section 71118 of H.R. 1, the law also referred to as the Working Families Tax Cut Act) that the CMS Chief Actuary must certify that new, renewed, or amended Section 1115 Medicaid demonstrations approved on or after January 1, 2027 will not increase federal Medicaid spending. The letter replaces the historical 'without waiver' expenditure-cap budget-neutrality model with a stricter no-increase standard and a more rigorous, individualized financial-impact analysis for each 1115-only activity. CMS followed on July 7 with a bulletin formally rescinding its 2015 'fast-track' review process for certain 1115 extensions, citing the new actuarial requirement. For California, this narrows the room available when CalAIM's Section 1115 waiver — which funds Enhanced Care Management and Community Supports that many FQHCs bill through managed-care plans — comes up for renewal ahead of its December 31, 2026 expiration; states with 2027 renewals in the pipeline should expect added actuarial documentation burden.

The $50B rural health fund is now real money with real deadlines: Florida June 17, Alaska June 22, Indiana July 1, Tennessee July 6-20 — and FQHCs must compete for every dollar

Six months after CMS announced all 50 states' Rural Health Transformation Program Year-1 awards (Dec 29, 2025; $147M for New Jersey to $281M for Texas), the state sub-grant windows FQHCs can actually apply to are opening in a cluster: Florida's RFA closes June 17; Alaska's $272M application portal closes June 22; Indiana's $120M GROW coalition applications are due July 1; Tennessee's CARE Grant RFP runs July 6-20; West Virginia is posting $60M+ in rolling two-week windows. The fine print that decides who benefits: CMS caps rural-hospital/provider allocations, the money is one-time against permanent Medicaid cuts (Georgetown CCF calls the mismatch structural), at least 32 states wrote CHW workforce development into their plans (NASHP), Tennessee tied full funding to eliminating Certificate of Need by January 2027, and several states route funds through regional coalitions FQHCs must join rather than apply to alone. CMS reviews state progress beginning late summer; Year-2 amounts land in October. For rural health centers this is the largest additive federal money of 2026 — but it must be chased state by state, deadline by deadline.

The first post-H.R. 1 budget season splits the states: New York invests $80M in FQHCs while Colorado cuts rates 2% and New Jersey stares into a $3.6B/yr hole

With ~46 states starting FY2027 on July 1, the first budgets written entirely after H.R. 1 sort the country into camps. BACKFILLERS: New York ($1.5B in new Medicaid funding including $80M specifically for FQHC rates — the largest named FQHC investment of the cycle — plus a permanent provider tax), Connecticut ($5M routed directly to FQHCs from its Federal Cuts Response Fund), New Mexico ($40M for immigrant coverage plus an insurer surtax), and Minnesota ($205M to stabilize HCMC plus a $500M hospital uncompensated-care reserve). CUTTERS: Colorado (2% Medicaid provider rate cut effective July 1, with 65% of its health centers already at negative margins), Florida (special session weighing 3% hospital cuts), and structurally, New Jersey ($3.6B/yr permanent federal loss as its provider-tax mechanism phases down — the inverse of New York's). California sits unresolved past its June 15 deadline with the MCO tax in the balance. The divergence is the strategy lesson: the same federal law produces opposite state responses depending on whether a provider-tax mechanism survives — which is exactly what California is fighting about this week.

House Appropriations approves the FY2027 Labor-HHS bill 34-28 — with no Community Health Center Fund extension, the Dec 31 cliff now rides on a bill that doesn't exist yet

The House Appropriations Committee approved the FY2027 Labor-HHS-Education bill on June 9, 2026 on a party-line 34-28 vote, funding HHS about 3% (~$5.6B) below FY2026. The structural point for health centers: appropriations only carry the ~$1.9B discretionary slice of Health Center Program funding — the mandatory Community Health Center Fund (~$4.6B/yr, ~70% of federal CHC money) expires December 31, 2026 and requires separate reauthorizing legislation from Energy & Commerce / Senate HELP, where no bill has been introduced. The party-line vote also signals FY2027 appropriations won't pass by October 1, making another continuing resolution near-certain — a CR holds discretionary funding flat but does nothing for the mandatory cliff. NACHC's 288-House/57-Senate sign-on letters remain the only vehicle-in-waiting; the realistic path is a year-end package, which means health center boards should plan Q1-2027 cash positions assuming the cliff resolves late, retroactively, or partially. WORKFORCE LINE ITEMS (added 2026-07-20, per an ACU policy update): within that same House bill the National Health Service Corps receives $133.1 million in discretionary funding, a $3.1M / 2.3% increase over FY2026, and HRSA Title VII/VIII workforce programs are held flat at $825.8 million. At a June 17 markup the Senate HELP Committee declined to adopt an amendment increasing NHSC funding, though Title VII/VIII reauthorization remains in play. NHSC loan repayment and scholarships are a core FQHC clinician-recruitment tool, so a 2.3% discretionary bump alongside an unresolved mandatory cliff is the shape of the whole federal picture: the recruiting subsidy inches up while the base funding it recruits into stays unresolved.

Revenue Recovery: CY2026 Opens New Medicare Care-Management Codes (APCM + 3 BHI Add-Ons) Billable by FQHCs — No Downside Risk

The CY2026 Physician Fee Schedule (CMS-1832-F, effective Jan 1, 2026) reshaped FQHC/RHC care-management billing — and most centers haven't operationalized it. Three actions: (1) Bill APCM monthly per-patient codes G0556 ($15.20), G0557 ($48.84), G0558 ($107.07) — centers shifted off G0511 on July 1, 2025; (2) Layer the three NEW behavioral-health-integration add-on codes G0568 (initial CoCM month), G0569 (subsequent CoCM), G0570 (general BHI) — billable alongside APCM with no time-based documentation requirement, making ~$263/patient/month achievable for complex BH-integrated patients; (3) Stop billing the now-sunset bundled codes G0512 and G0071 (Jan 1, 2026) and unbundle to the individual codes or lose the revenue. This is a no-downside-risk monthly revenue stream that helps build resilience ahead of the signed budget's July 1, 2027 UIS/PPS sensitivity window — and it rewards the care-management and behavioral-health-integration work most CA FQHCs already do.

HHS MAHA Initiative Reshapes HRSA Grant Priorities — Chronic Disease Focus

HHS Make America Healthy Again (MAHA) priorities are reshaping FY2026 HRSA grant narratives toward chronic disease prevention, nutrition, preventive health education, cancer screening, mental health, reducing medication overreliance, and environmental health. Strategic implication: CA FQHCs serving LGBTQ+, LEP, undocumented, or high-social-need populations should preserve the service model while reviewing SAC language for MAHA-compatible framing. Conversely, FQHCs with strong chronic disease management programs can position those outcomes more clearly. Pairs with the HHS RFI on AI in clinical care (closed Jan 28) — federal grant infrastructure shifting simultaneously across multiple programs.

Continuing Resolution Funds CHCF at $4.6B Through December 2026 — Multi-Year Reauthorization NOT Included, Cliff Remains Existential Risk

NACHC confirmed in the most recent Continuing Resolution analysis: the Community Health Center Fund (CHCF) is funded at $4.5B annualized for the current FY and $4.6B for FY2026 — but only authorized through December 2026. Telehealth flexibilities and key workforce programs (NHSC, Teaching Health Center, Title VII Section 747) are extended through CHCF expiration. Multi-year reauthorization NACHC has been pushing for is NOT included. Strategic implication: the December 2026 CHCF cliff is one of the major existential funding risks on the calendar for CA FQHCs, alongside H.R. 1 implementation specifics. CPCA, NACHC, and CCALAC will increasingly center December 2026 in advocacy through the rest of 2026. CFOs should: (1) build December 2026 cliff scenarios into FY26-27 budgets, (2) accelerate cash reserve targets (NACHC recommends 90+ days operating reserves), (3) line up bridge financing options before the cliff, (4) consider 340B Medicare Advantage strategy and PACE expansion as diversification. NACHC P&I 2027 (typically February) will likely be especially consequential if reauthorization remains unresolved.

First Implementation Data: Work Requirements Squeezing Health Centers — Bluestem Health Faces $600K Loss, Vermont Clinic $3M

Governing.com reports the first real-world impact data from work requirements implementation. Bluestem Health in Nebraska faces $600K annual revenue loss. A Vermont clinic projects $3M in lost revenue. Health centers are legally required to serve all patients regardless of ability to pay, creating a financial death spiral: lost Medicaid revenue but increased uninsured demand. Of 33M national health center patients, approximately half are on Medicaid.

CMS Opens $100M MAHA ELEVATE Model for Lifestyle Medicine — FQHCs Eligible

CMS Innovation Center is funding up to 30 cooperative agreements (~$3.3M each over 3 years) for whole-person lifestyle medicine approaches in Original Medicare. FQHCs are explicitly eligible. This is the first CMS model branded under MAHA priorities. Awards launch September 2026 (first of two cohorts; second cohort 2027). All proposals must incorporate nutrition or physical activity — signaling policy direction toward 'lifestyle' interventions over traditional SDOH approaches.

Trump FY2027 Budget Proposes $3B for Health Centers — a 54% Cut from $6.5B Enacted in FY2026

The FY2027 budget proposes only $3 billion for Health Centers ($1.8B discretionary + $1.1B mandatory), down from $6.5B enacted in FY2026 (which included the $4.6B Community Health Center Fund). The budget also proposes eliminating HRSA as a standalone agency by consolidating it into the new 'Administration for a Healthy America' (AHA) with a total AHA budget of $17.5B (down $8.6B from component agencies' FY2026 levels). Health Workforce gets only $1.1B, threatening NHSC loan repayment.

FY2027 Budget Proposes Eliminating NIMHD as 'DEI Expenditure' — Cuts Federal Research Pipeline for FQHC Cultural Competency Models

The White House FY2027 budget proposes eliminating the National Institute on Minority Health and Health Disparities (NIMHD), characterizing it as 'replete with DEI expenditures.' The proposal also cuts CMS health equity program funding by $674M. NIMHD funds the research base for culturally concordant care models, CHW effectiveness studies, and the SDOH interventions that undergird FQHC clinical programs. While Congress is unlikely to pass the proposal verbatim, even partial cuts would sever the federal research pipeline that validates FQHC cultural humility and health equity approaches — compounding the earlier HHS OMH restructuring.

Commonwealth Fund: 5.6 Million Health Center Patients Face Coverage Loss, $32B Revenue Impact Over 5 Years

The Commonwealth Fund projects 5.6 million community health center Medicaid patients in expansion states will lose coverage under H.R. 1 work requirements. Revenue losses could approach $32 billion over five years. More than half of CHCs already operate with negative margins, and 2 in 5 have 90 days or less cash on hand. This is the most comprehensive projection of the financial impact on FQHCs specifically.

STAT News: FQHCs' Greatest Threat Isn't Funding Cuts — It's Structural Insolvency

A major STAT News analysis argues that FQHCs face an existential financial crisis beyond federal funding cuts. FQHC net margins collapsed from 5.3% (2020-2022) to negative 2.1% in 2024. The community health center program posted a 2% program-wide financial loss in 2025. Federal grants remained flat 2019-2023 while healthcare costs rose 25%+. One restructured FQHC found core medical services operating at a '$5/visit loss.' Author calls for rigorous financial discipline and program performance analysis as 'foundational to mission delivery.'

HRSA Has Lost ~25% of Staff — Grant Management and FQHC Oversight Capacity Severely Degraded

HRSA has lost approximately 25% of its workforce since February 2026 through DOGE-directed reductions and voluntary departures, according to KFF Health News. Auditors, grant managers, and field staff overseeing FQHC compliance and site visits are among those lost. The Administration's proposed FY2026 budget would eliminate HRSA (per KFF Health News), consolidating functions and cutting programs including rural-hospital grants, workforce training, and Ryan White. FQHCs should not interpret reduced oversight capacity as reduced compliance risk — enforcement actions already in motion continue, and grant payment delays are an emerging operational concern.

H.R. 1 Creates $50B Rural Health Transformation Fund — Silver Lining for Rural FQHCs

Buried within H.R. 1's massive Medicaid cuts is a $50 billion Rural Health Transformation Program ($10B/year for 5 years, FY 2026–2030) funding grants for rural FQHCs, hospitals, and behavioral health providers. California's likely allocation: ~$500M/year via competitive grants. Eligible applicants include FQHCs in rural shortage areas — targeting North State, North Coast, and Central Valley regions. While it does not offset the far larger Medicaid losses, it represents the first new federal FQHC investment channel since the ACA.

CHCF $4.6B Authorization Expires December 2026 — No Multi-Year Reauthorization

The Consolidated Appropriations Act 2026 set the Community Health Center Fund at $4.6B for FY2026, but authorization extends only through December 2026 — breaking from the historical 5-year reauthorization pattern. This creates hiring hesitancy, slows capital investment, and narrows strategic planning windows for all FQHCs nationwide.

HRSA FY2026 Health Center Grants Now MAHA-Aligned — Chronic Disease Focus

HRSA's FY2026 Health Center Program Service Area Competition materials now emphasize Make America Healthy Again (MAHA)-aligned priorities: nutrition, chronic disease management, preventive health education, cancer screening, mental health services, reducing medication overreliance, and environmental health. The strategy implication is not a simple grant-dollar headline; it is narrative alignment. FQHCs should translate equity, language-access, and social-needs work into chronic-disease, access, prevention, and measurable-outcomes language while monitoring tranche-specific HRSA award notices before using dollar assumptions.

Community Health Centers Posted 2% Program-Wide Financial Loss in 2025 — Structural Strain Before H.R. 1 Cuts

The community health center program posted a 2% program-wide financial loss for 2025 — signaling structural strain even before H.R. 1 Medicaid cuts take full effect. With $4.6B in CHCF funding only authorized through December 2026, and Medicaid accounting for 43% of health center revenue nationally, even modest shifts in productivity, payer mix, or workforce costs can destabilize organizations. The negative margin came despite the largest CHCF funding increase in a decade, underscoring that grant funding alone cannot offset structural revenue erosion.

RAND: State Medicaid Budgets Will Decline by $665B Over Next Decade Under H.R. 1

A RAND Health analysis published by Stateline finds state Medicaid budgets will be reduced by a total of $665 billion over the next decade under H.R. 1. With FQHCs deriving ~43% of revenue from Medicaid, the projected decline signals sustained revenue compression for California's 213 community health centers. CBO estimates 11.8M will directly lose coverage, plus 3.1M through marketplace plans.

GWU Research: Medicaid Cuts Will Also Devastate FQHC Medicare Patients — Cross-Subsidy at Risk

Geiger Gibson Program at GWU finds Medicaid cuts won't just affect Medicaid patients — they'll undermine care for 7.4M Medicare patients at community health centers. FQHCs use Medicaid revenue to cross-subsidize Medicare and uninsured care. If Medicaid volume drops, health centers may reduce hours, close sites, or cut services that Medicare patients depend on. CHCs operated at -2% average margin in 2024.

Johns Hopkins Model: Ending Ryan White Program Would Increase New HIV Infections 49% by 2030

A Johns Hopkins computer simulation published in Annals of Internal Medicine projects that eliminating federal Ryan White HIV/AIDS Program funding would increase new HIV infections by 49% nationwide by 2030 — representing thousands of preventable infections annually. For FQHCs receiving Ryan White Part C/D funding: this threat makes ECM revenue layering and Medi-Cal billing optimization urgently important as a financial hedge. The 2026 National Ryan White Conference (Aug 4-7, Washington DC) will focus on 'Strengthening our Foundation' — FQHC leaders should attend for advocacy and sustainability planning.

CMS Pays AI MORE Than Human Interpretation for Diabetic Retinopathy Screening — CPT 92229 = $40.28 (2024) vs 92228 = $29.14

CMS deliberately reimburses autonomous AI more than human interpretation for diabetic retinopathy screening. CPT 92229 (autonomous AI imaging) = $40.28 (2024); CPT 92228 (MD interpretation) = $29.14; CPT 92227 (staff review) = $17.35. The price differential is intentional policy: CMS uses reimbursement to drive autonomous AI adoption in primary care settings — the policy tailwind for FQHCs is real. Combined with $40.28 reimbursement vs ~$15-25K refurbished Topcon NW400 fundus camera, AI DR screening can pay for the equipment quickly for an FQHC with a Type 2 diabetes panel. Plus HEDIS EED quality measure improvement (only 64.8% of US diabetics get annual exam vs HP2030 70.3% target). One of the clearest vision technology scenarios for FQHCs to evaluate before deciding whether to adopt at scale.